Experiences of gender-diverse youth during the COVID-19 pandemic in Canada: A longitudinal qualitative study
Everest, Louis, Henderson, Jo, Dixon, Mahalia, Relihan, Jacqueline, Hawke, Lisa D
Published in PloS one (16.11.2023)
Published in PloS one (16.11.2023)
Get full text
Journal Article
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
Everest, Louis, Chen, Bingshu E, Hay, Annette E, Cheung, Matthew C, Chan, Kelvin K W
Published in BMC medical research methodology (03.08.2023)
Published in BMC medical research methodology (03.08.2023)
Get full text
Journal Article
Examining the association between oncology drug clinical benefit and the time to public reimbursement
Thomson, Sasha, Everest, Louis, Witzke, Noah, Jiao, Tina, Delos Santos, Seanthel, Nguyen, Vivian, Cheung, Matthew C., Chan, Kelvin K. W.
Published in Cancer medicine (Malden, MA) (01.01.2022)
Published in Cancer medicine (Malden, MA) (01.01.2022)
Get full text
Journal Article
Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
Jiang, Di Maria, Chan, Kelvin K. W., Jang, Raymond W., Booth, Christopher, Liu, Geoffrey, Amir, Eitan, Mason, Robert, Everest, Louis, Elimova, Elena
Published in Cancer medicine (Malden, MA) (01.04.2019)
Published in Cancer medicine (Malden, MA) (01.04.2019)
Get full text
Journal Article
Acute and Chronic Kidney Dysfunction Associated with Anaplastic Lymphoma Kinase (ALK) Inhibitors: FR-PO279
Ullur, Avinash Rao, Pinard, Louis, Everest, Louis C., Khan, Khaleeq, Zhan, Luna J., Liu, Geoffrey, Kitchlu, Abhijat
Published in Journal of the American Society of Nephrology (01.11.2023)
Published in Journal of the American Society of Nephrology (01.11.2023)
Get full text
Journal Article
Leukemia Incidence by Occupation and Industry: A Cohort Study of 2.3 Million Workers from Ontario, Canada
Samsel, Konrad, Navaneelan, Tanya, DeBono, Nathan, Everest, Louis, Demers, Paul A, Sritharan, Jeavana
Published in International journal of environmental research and public health (27.07.2024)
Published in International journal of environmental research and public health (27.07.2024)
Get full text
Journal Article
Comparison of internal and external reference populations for occupational cancer surveillance in a cohort drawn from a diverse workforce
Everest, Louis, Tan, Shirui, Navaneelan, Tanya, Demers, Paul A., DeBono, Nathan, Berriault, Colin, Sritharan, Jeavana
Published in American journal of industrial medicine (01.09.2024)
Published in American journal of industrial medicine (01.09.2024)
Get full text
Journal Article
Assessing long-term survival improvement of immune-checkpoint inhibitors (ICI) anticancer agents approved by the Food and Drug Administration: A meta-analysis of randomized controlled trials (RCTs)
Everest, Louis, Chan, Kelvin K., Saluja, Ronak, Shah, Monica, Nguyen, Vivian
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Examining the relationship between the clinical benefit of oncology drug indications and the time from pan-Canadian Oncology Drug Review (pCODR) recommendation to public reimbursement
Thomson, Sasha, Everest, Louis, Witzke, Noah, Delos Santos, Seanthel, Cheung, Matthew C., Chan, Kelvin K.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Reassessing the net health benefit (NHB) of FDA approved cancer drugs with evolution of evidence using the American Society of Clinical Oncology Value Framework (ASCO-VF)
Delos Santos, Seanthel, Witzke, Noah, Arciero, Vanessa Sarah, Rahmadian, Amanda Putri, Everest, Louis, Chan, Kelvin K.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Examining Convergent Construct Validity and Inter-Rater Reliability Between ESMO-MCBS and ASCO-VF When Evaluating Hematologic Malignancies
Cheung, Matthew, Albakri, Ihsan, Mason, Robert, Saluja, Ronak, Cheng, Sierra, Arciero, Vanessa, Everest, Louis, Chan, Kelvin
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Immunotherapy (IO) versus non-IO for oncology drugs: Comparing survival benefits (SB) using restricted mean survival time
Rahmadian, Amanda Putri, Delos Santos, Seanthel, Parshad, Shruti, Everest, Louis, Cheung, Matthew C., Chan, Kelvin K.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival Time
Rahmadian, Amanda Putri, Delos Santos, Seanthel, Parshad, Shruti, Everest, Louis, Cheung, Matthew C, Chan, Kelvin K
Published in Journal of the National Comprehensive Cancer Network (01.03.2020)
Published in Journal of the National Comprehensive Cancer Network (01.03.2020)
Get more information
Journal Article
Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to assess the value of abiraterone acetate (AA) and enzalutamide (E) in advanced prostate cancer: clinical value and cost considerations
Wong, Sarah, Everest, Louis, Jiang, Di Maria, Saluja, Ronak, Chan, Kelvin K., Sridhar, Srikala S.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article